For: | Wietzke-Braun P, Meier V, Braun F, Ramadori G. Combination of “low-dose” ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World J Gastroenterol 2001; 7(2): 222-227 [PMID: 11819764 DOI: 10.3748/wjg.v7.i2.222] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i2/222.htm |
Number | Citing Articles |
1 |
Xue-Song Liang, Jian-Qi Lian, Yong-Xing Zhou, Qing-He Nie, Chun-Qiu Hao. A small yeast RNA inhibits HCV IRES mediated translation and inhibits replication of poliovirus <italic>in vivo</italic>. World Journal of Gastroenterology 2003; 9(5): 1008-1013 doi: 10.3748/wjg.v9.i5.1008
|
2 |
Rashmi Kumar, Piyush Tripathi, Madan Baranwal, Sudhakar Singh, Sanjeev Tripathi, Gopa Banerjee. Randomized, Controlled Trial of Oral Ribavirin for Japanese Encephalitis in Children in Uttar Pradesh, India. Clinical Infectious Diseases 2009; 48(4): 400 doi: 10.1086/596309
|
3 |
Xin-Xin Zhang, Shen-Ying Zhang, Jing Liu, Zhi-Meng Lu, Yuan Wang. Expression of hepatitis C virus hypervariable region 1 and its clinical significance. World Journal of Gastroenterology 2003; 9(5): 1003-1007 doi: 10.3748/wjg.v9.i5.1003
|
4 |
Xue-Bing Yan, Serena Battaglia, Delphine Boucreux, Zhi Chen, Christian Brechot, Nicole Pavio. Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR. Virus Research 2007; 125(1): 79 doi: 10.1016/j.virusres.2006.12.010
|
5 |
Perdita Wietzke-Braun, Felix Braun, Burckhart Sattler, Giuliano Ramadori, Burckhardt Ringe. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis. World Journal of Gastroenterology 2004; 10(15): 2213-2217 doi: 10.3748/wjg.v10.i15.2213
|
6 |
Song Chen, Yu-Ming Wang. Genetic evolution of structural region of hepatitis C virus in primary infection. World Journal of Gastroenterology 2002; 8(4): 686-693 doi: 10.3748/wjg.v8.i4.686
|
7 |
Dilek Oguz, Bahattin Cicek, Levent Filik, Bulent Odemis, Mesut Kilic, Engin Altintas, Neslihan Zengin, Emin Altiparmak. Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1). World Journal of Gastroenterology 2005; 11(4): 580-583 doi: 10.3748/wjg.v11.i4.580
|
8 |
Yukiko Ito, Natsuyo Yamamoto, Ryo Nakata, Yoshihisa Kato, Masashi Iori, Keisuke Sakai, Tamiko Takemura, Ryosuke Tateishi, Haruhiko Yoshida, Takao Kawabe, Masao Omata. Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy. World Journal of Gastroenterology 2005; 11(45): 7218-7221 doi: 10.3748/wjg.v11.i45.7218
|
9 |
Perdita Wietzke-Braun, Volker Meier, Katrin Neubauer-Saile, Sabine Mihm, Giuliano Ramadori. Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients. World Journal of Gastroenterology 2005; 11(39): 6188-6192 doi: 10.3748/wjg.v11.i39.6188
|
10 |
Perdita Wietzke-Braun, Felix Braun, Peter Schott, Giuliano Ramadori. Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?. World Journal of Gastroenterology 2003; 9(4): 745-750 doi: 10.3748/wjg.v9.i4.745
|
11 |
Yan-Wei Zhong, Jun Cheng, Gang Wang, Shuang-Shuang Shi, Li Li, Ling-Xia Zhang, Ju-Mei Chen. Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry. World Journal of Gastroenterology 2002; 8(5): 863-867 doi: 10.3748/wjg.v8.i5.863
|